Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?

13 Jul 2021

Abstract excerpt

Two adenovirus-based vaccines, ChAdOx1 nCoV-19 and Ad26.COV2.S, and two mRNA-based vaccines, BNT162b2 and mRNA.1273, have been approved by the European Medicines Agency (EMA), and are invaluable in preventing and reducing the incidence of coronavirus disease-2019 (COVID-19). Recent reports have pointed to thrombosis with associated thrombocytopenia as an adverse effect occurring at a low frequency in some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Heparin-Induced Thrombocytopenia and Thrombosis
Share to Platelet Disorders and Treatments
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34356644
DOI: 10.3390/biom11071020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?PMID 34356644Read ↗

COVID-19 vaccine-associated cerebral venous thrombosis in GermanySemantic proximity Read ↗

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesSemantic proximity Read ↗

“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccinesSemantic proximity Read ↗

Arterial and Venous Thrombosis in COVID-19 Disease: From Molecular Pathway to Vaccine AdministrationSemantic proximity Read ↗

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysisSemantic proximity Read ↗

Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV ‐2 vaccination: A black swan eventSemantic proximity Read ↗

Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling PathwaysSemantic proximity Read ↗

Cerebral Venous Sinus Thrombosis After a Third Dose of mRNA COVID-19 Vaccine in an Adolescent: A case reportSemantic proximity Read ↗

Cerebral Venous Sinus Thrombosis after a Third Dose of mRNA COVID-19 Vaccine in an AdolescentSemantic proximity Read ↗

Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS StudySemantic proximity Read ↗

Changes in Thrombosis-Related Parameters After AstraZeneca COVID-19 Vaccination in A Male Volunteer: A Case ReportSemantic proximity Read ↗

Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.